您好,欢迎访问三七文档
当前位置:首页 > 商业/管理/HR > 经营企划 > 波士顿科学公司简介2013
波士顿科学公司简介TOPU,Owen2BostonScientificCorporationConfidential波士顿科学全球的机构•总部设在美国麻省波士顿地区的内提克市Natick•在40国家直接进行销售;全球雇有17,500+员工•16个主要生产地在美国,爱尔兰和墨西哥直销地区3BostonScientificCorporationConfidential波士顿科学的使命•Toimprovethequalityofpatientcareandtheproductivityofhealthcaredeliverythroughthedevelopmentandadvocacyofless-invasivemedicalprocedures.•拥护和发展微创介入技术,以提高病人的治疗质量及卫生保健的生产力。•Thisisaccomplishedthroughthecontinuingrefinementofexistingproductsandproceduresandtheinvestigationanddevelopmentofnewtechnologieswhichcanreducerisk,trauma,cost,proceduretimeandtheneedforaftercare.•通过持续改善我们现有的产品、不断的研发新的技术,以减少风险,损伤,费用,手术时间和术后调养來达到的。4BostonScientificCorporationConfidentialJohnTobinPresidentandCEOJohnAbeleCo-FounderPeteNicholasChairmanoftheBoard5BostonScientificCorporationConfidential引领介入技术的发展•1979波士顿科学的创始人JohnAbele和PeteNicholas成立公司。•1980-1990公司在打开国际市场的同时,通过收购与兼并、产品开发来扩大产品线。•1990-2000公司收购与兼并了超过15家公司,产品从3,000种激增到约10,000种。并于1992年在美国纽约证券交易所上市股票。雇员从3,000人增加到9,000人。•2000-2003波士顿科学公司大大增加了对研发的投资,专注于开发革命性的科技产品,如药物释放冠脉支架。同时收购与联合了20家公司。•2003-2004公司上市了许多革命性产品,包括药物释放冠脉支架系,Matrix可脱弹簧圈等,员工增加到15,000人•2006-2008公司收购Guidant,销售额突破80亿美元,员工人数超过2万人。•2010-2012公司全球员工超过25000人,在全球排名财富500强NO.335.6BostonScientificCorporationConfidential强烈使命感铸就一段成长的传奇238131622314771991161592303153804491,1911,5511,8312,2342,8422,6642,6732,9193,4765,6246,2837,821'79'80'81'82'83'84'85'86'87'88'89'90'91'92'93'94'95'96'97'98'99'00'01'02'03'04'05'06全球介入医疗领域的领导者JohnAbeleandPeteNicholaspartnertoformBostonScientificBSCgoespublicwithIPOonNYSEBSCacquireseightcompaniesintwoyearsFirstclinicaltrialofdrug-elutingstentRevenue($Millions)PhaseIVCRMIntegrationPhaseIIStrategicMass(ViaAcquisitions)PhaseILess-InvasiveMedicinePioneer/LeaderPhaseIIIStentIntegration&Drug-ElutingStentLeadershipTAXUSExpressU.S.FDAapprovalBSCacquiresGuidantCorp.股票上市战略性的并购过程新的里程碑7BostonScientificCorporationConfidential微创伤技术对人体的应用VASCULARSURGERYONCOLOGYENDOSCOPYPERIPHERALVASCULARNEUROMODULATIONELECTROPHYSIOLOGYGYNECOLOGYCARDIOVASCULARNEUROVASCULARUROLOGY神经调节神经血管介入内镜术泌尿介入妇科介入肿瘤介入血管外科电生理外周血管介入心脏介入8BostonScientificCorporationConfidential不懈的努力让我们成为了各领域的领导者波士顿产品组产品分类全球市场占有率排名CardiacRhythmManagement(CRM)ImplantableCardioverterDefibrillators2WirelessRemotePatientMonitoring1InterventionalCardiologyDrug-ElutingStents2*BalloonCatheters1GuideWires&Catheters2DiagnosticCatheters2Atherectomy1IVUS1NeurovascularDetachableCoils1PeripheralVascular/NonvascularStents1AAAGrafts1EndosurgeryGIMetalStents1BiliaryDevices1GIBiopsyDevices1GIDilationBalloons1NeuromodulationPainManagement2CochlearImplants2*#1shareintheU.S.9BostonScientificCorporationConfidential部分产品系列Over25yearsofInnovationhasledtoabroadportfolioofmorethan15,000productsBalloonsDetachableCoilsGraftsEnteralFeedingAblationEmbolicsCardiacMappingStentsStoneRetrievalEmbolicProtectionPeripheralDilatationBiopsySystemsUreteralStentsCatheters/GuidewiresNeuro-stimulation10BostonScientificCorporationConfidentialProlieve™ThermodilatationSystemEndosurgeryGroupMedicalConditions•Malignant&BenignTumors•GastrointestinalDiseases•GastrointestinalCancers•Incontinence•Abscesses•EndStageRenalDisease•BenignProstaticHyperplasia•Gallstones&UrinaryStoneDisease•UterineFibroids&MenorrhagiaSolutions•EnternalFeedingProcedures•GIDilation/Stenting•MicrowaveDilation•EndometrialAblation•Mid-UrethralSling•Biliary,UrinaryDrainage5136416975801963242612262071861661432002200320042005OncologyUrology/GynecologyEndoscopyRevenueTrendbyBusiness($Millions)8529721,0881,22813.0%CAGR11BostonScientificCorporationConfidentialWeAchieveGlobalLeadershipinourKeyMarketsEndosurgery(Endoscopy,Oncology,Urology,Gynecology)•75%ofsalesfrommarketleadingproducts•Represents20%ofBSCtotalbusinessBSC35%Others24%Bard14%Cook9%Conmed3%AMS4%Cytyc3%J&J3%Olympus5%Source:BSCinternalestimatesInterventionalCardiology•90%+ofsalesfrommarketleadingproducts•Represents72%ofBSCtotalbusinessBSC43%J&J35%Guidant7%Medtronic6%Other9%12BostonScientificCorporationConfidentialBSChasmadesignificantinternalR&DinvestmentstochampionnewideasandproductsintonewmarketsNewProductDevelopmentDeliveringwhat’snext.TM$275$343$452$569$68020012002200320042005R&DInvestment研究与开发$Millions2,5352,8923,3073,6174,01620012002200320042005U.S.PatentsIssuedAtyear-end2005:7,800+applicationspendingworldwide美国专利权13BostonScientificCorporationConfidentialTheresultofourHybridModelisaRobustProductPipelineProductPrioritiesthatwillshapeourfutureCardiacRhythmManagement(CRM)CameronHealthcardioverterdefibrillatorEndovascularAorticRepair(EVAR)TriVascularAAAStentGraft1Next-GenerationDrug-ElutingStentsTAXUS®Liberté™2Drug-ElutingStentCarotidStentEndoTexNexStent1CarotidStent1.CAUTION:Investigationaldevice.LimitedbyFederallawtoinvestigationaluse.2.NotavailableforsaleintheUnitedStates.3.HumanitarianUseDevice.PainManagementPrecision®SpinalCordStimulationSystemPainManagementbion®Microstimulator1Single-UseEndoscopeEndovationsEndoscopySuite1,2NeurovascularStentWingspan™StentSystemwithGateway™PTABalloonCatheter3BSCInternationalBSCIntercontinentalConfidentialinformationofBostonScientificCorporation.Donotcopyordistribute.International
本文标题:波士顿科学公司简介2013
链接地址:https://www.777doc.com/doc-3746514 .html